Evidence map›Paper›PMID 29462956›Full record

ArticleMolecules (Basel, Switzerland)2018

Preparation of Novel Homodimers Derived from Cytotoxic Isoquinolinequinones. A Twin Drug Approach.

Juana Andrea Ibacache, Judith Faundes, Margarita Montoya, Sophia Mejías, Jaime A Valderrama

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Discovery of Potent IsoquinolinequinoneJournal of medicinal chemistry · 2024
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Juana Andrea IbacacheFacultad de Química y Biología, Universidad de Santiago de Chile, Alameda 3363, Casilla 40, Santiago 9170022, Chile. juana.ibacache.r@usach.cl.
Judith FaundesFacultad de Química y Biología, Universidad de Santiago de Chile, Alameda 3363, Casilla 40, Santiago 9170022, Chile. judith.faundes@usach.cl.
Margarita MontoyaFacultad de Química y Biología, Universidad de Santiago de Chile, Alameda 3363, Casilla 40, Santiago 9170022, Chile. margarita.montoya@usach.cl.
Sophia MejíasFacultad de Química y Biología, Universidad de Santiago de Chile, Alameda 3363, Casilla 40, Santiago 9170022, Chile. sophia.mejias@usach.cl.
Jaime A ValderramaFacultad de Ciencias de la Salud, Universidad Arturo Prat, Casilla 121, Iquique 1100000, Chile. jaimeadolfov@gmail.com.
Universidad de Santiago de Chile · CLArturo Prat University · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis of five novel homodimers is reported based on the anilinoisoquinolinequinone scaffold. In these twin-drug derivatives, two units of the anilinoquinone pharmacophores are linked through a methylene spacer. The formation of dimers was achieved by reaction of isoquinolinequinones with 4, 4'-diaminodiphenylmethane via a sequence of two oxidative amination reactions. A preliminary in vitro screening of the homodimers reveals moderate to high cytotoxic activities against MDA-MB-21 breast adenocarcinoma and B16-F10 murine metastatic melanoma cell lines. The asymmetrical homodimer

Indexed as

Aniline CompoundsAnimalsAntineoplastic AgentsBenzoquinonesBreast NeoplasmsCell Line, TumorDrug Screening Assays, AntitumorFemaleHumansIsoquinolinesMelanoma, ExperimentalMiceanilineAniline CompoundsAntineoplastic AgentsBenzoquinonesisoquinolineIsoquinolinesquinoneamination reactionanilinoisoquinolinequinonescytotoxic activityhomodimerstwin drugs

Identifiers

PMID29462956
PMCPMC6100386
OpenAlexW2791660712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.